# Abiosciences

> Abiosciences is a biotechnology research and drug discovery company that provides single-cell and spatial omics services, bioinformatics analysis, curated datasets and a browser for target exploration while developing targets and antibody assets for licensing.

- **Founded:** 2018
- **Headquarters:** South San Francisco, United States
- **Founders:** Zemin Zhang (Founder)
- **Products:** Single-cell and spatial omics services, Bioinformatics services, OmniDatasets, OmniBrowser, Target and antibody licensing
- **Notable:** Company reports more than 120 million cells, 4,300 datasets and 2,200 studies in its Omni Single Cell Database., A December 2022 partner announcement reported more than 300 cooperating organizations and support for 16 research publications., Company says it operates research and development sites in Beijing, Shanghai and South San Francisco.

## Products & services

- **Single-cell and spatial omics services** — Sample preparation, library construction, sequencing and analysis for single-cell RNA, immune profiling, chromatin accessibility and spatial transcriptomics.
- **Bioinformatics services** — Standard and customized analyses including cell annotation, differential expression, trajectory and cell communication analysis.
- **OmniDatasets** — Curated and integrated single-cell datasets and reports for target and biomarker investigation.
- **OmniBrowser** — Interactive search, display and analysis of the company’s single-cell database.
- **Target and antibody licensing** — Validated therapeutic targets and related antibody assets offered for licensing or co-development.

## Achievements

- Company reports more than 120 million cells, 4,300 datasets and 2,200 studies in its Omni Single Cell Database.
- A December 2022 partner announcement reported more than 300 cooperating organizations and support for 16 research publications.
- Company says it operates research and development sites in Beijing, Shanghai and South San Francisco.

## Latest updates

- **2022-12** — Mission Bio and Abiosciences announced a bioinformatics collaboration for hematologic cancer research.
- **2021-05** — Analytical BioSciences announced a Series A4 financing led by Sequoia Capital China.

## Links

- Website: https://www.abiosciences.com/
- LinkedIn: https://www.linkedin.com/company/abiosciences
- Twitter/X: https://twitter.com/AnalyticalBioS1
- Facebook: https://www.facebook.com/Abiosciences

---

Profile page: https://yespress.io/abiosciences
Published by YesPress — https://yespress.io
Last updated: 2026-09-28